Wedbush Maintains Outperform on Zura Bio, Lowers Price Target to $10

Benzinga · 2d ago
Wedbush analyst Martin Fan maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $22 to $10.